BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 18727618)

  • 1. Prognostic variables to predict cancer-related death in incidental renal tumours.
    Bensalah K; Pantuck AJ; Crepel M; Verhoest G; Méjean A; Valéri A; Ficarra V; Pfister C; Ferrière JM; Soulié M; Cindolo L; De La Taille A; Tostain J; Chautard D; Schips L; Zigeuner R; Abbou CC; Lobel B; Salomon L; Lechevallier E; Descotes JL; Guillé F; Colombel M; Belldegrun AS; Patard JJ
    BJU Int; 2008 Nov; 102(10):1376-80. PubMed ID: 18727618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
    Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
    Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.
    Zubac DP; Bostad L; Gestblom C; Kihl B; Seidal T; Wentzel-Larsen T; Bakke AM
    Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
    J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.
    Patard JJ; Pantuck AJ; Crepel M; Lam JS; Bellec L; Albouy B; Lopes D; Bernhard JC; Guillé F; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferriere JM; Abbou CC; Colombel M; Belldegrun AS
    Eur Urol; 2007 Jul; 52(1):148-54. PubMed ID: 17240036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between the mode of presentation of renal tumors and patient survival].
    Patard JJ; Bensalah K; Vincendeau S; Rioux-Leclerq N; Guillé F; Lobel B
    Prog Urol; 2003 Feb; 13(1):23-8. PubMed ID: 12703350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.
    Steiner T; Knels R; Schubert J
    Eur Urol; 2004 Sep; 46(3):327-30. PubMed ID: 15306102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
    Capitanio U; Jeldres C; Patard JJ; Perrotte P; Zini L; de La Taille A; Ficarra V; Cindolo L; Bensalah K; Artibani W; Tostain J; Valeri A; Zigeuner R; Méjean A; Descotes JL; Lechevallier E; Mulders PF; Lang H; Jacqmin D; Karakiewicz PI
    BJU Int; 2009 Jan; 103(1):33-7. PubMed ID: 18990161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do broader indications for partial nephrectomy result in excess morbidity?].
    Verhoest G; Crepel M; Bernhard JC; Bellec L; Albouy B; Lopes D; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferrière JM; Abbou CC; Colombel M; Vincendeau S; Bensalah K; Manunta A; Guillé F; Patard JJ
    Prog Urol; 2008 Apr; 18(4):207-13. PubMed ID: 18501300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.
    Verhoest G; Veillard D; Guillé F; De La Taille A; Salomon L; Abbou CC; Valéri A; Lechevallier E; Descotes JL; Lang H; Jacqmin D; Tostain J; Cindolo L; Ficarra V; Artibani W; Schips L; Zigeuner R; Mulders PF; Mejean A; Patard JJ
    Eur Urol; 2007 May; 51(5):1298-304; discussion 1304-5. PubMed ID: 17174023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.
    Patard JJ; Leray E; Rioux-Leclercq N; Cindolo L; Ficarra V; Zisman A; De La Taille A; Tostain J; Artibani W; Abbou CC; Lobel B; Guillé F; Chopin DK; Mulders PF; Wood CG; Swanson DA; Figlin RA; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2005 Apr; 23(12):2763-71. PubMed ID: 15837991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.